This section covers people talking about different options for having children in families affected by inherited MND. There are many routes people take, including having children the usual way, but this section focuses on experiences of using genetic testing during or before pregnancy in order to prevent passing on a gene variant linked to MND. This section includes:
- What reproductive options are available
- Knowledge and views on pre-implantation genetic testing and pre-natal testing during pregnancy
- Experiences of using pre-implantation genetic testing
Hear people reflect on their experiences of deciding whether to have children, and talk about their future plans to start a family (including the options described below).
What reproductive options are available
Many people with MND running in the family choose not to let that affect their family planning choices. If they do have children the usual way, without any additional testing, there is the possibility that their children will not be affected anyway. It is important to remember that symptoms usually start in mid or later life, and that there is ongoing research looking at finding treatments. However, there are also options available for people who want to have a child without passing on a gene variant linked to inherited MND.
Where a genetic variant linked to inherited MND has been identified in the family, people may be able to have genetic testing. This can be done in two ways, either testing an embryo before pregnancy (pre-implantation genetic testing (PGT)) or pre-natal testing of an established pregnancy (explained below).
PGT uses the fertility treatment IVF (in vitro fertilisation) with the added step of genetic testing, and is available to some people who are at risk of passing on an inherited condition to their children. Embryos are produced through IVF and tested for the gene variant at a very early stage. Only embryos which do not carry the genetic variant would be transferred to the womb. This is sometimes also called PGD, preimplantation genetic diagnosis.
Pre-natal testing for inherited MND involves testing an established pregnancy for the genetic variant (pre-natal means ‘before birth’). This type of testing is sometimes called PND or pre-natal diagnosis. Pre-natal testing can be carried out as early as 11+ weeks of pregnancy using Chorionic Villus Sampling (CVS) to collect a sample of DNA from the pregnancy. Having a prenatal test is associated with an increased risk of miscarriage, and people wouldn’t be advised to choose this option if they would not consider terminating the pregnancy if the fetus was found to carry the genetic variant. Testing a pregnancy but not having a termination after a positive test result would take away the child’s right to choose whether to have the genetic test later in life.
In some cases, it may be possible for people to have PGT or pre-natal testing for inherited MND without needing to find out if they have inherited the genetic variant of inherited MND themselves (non-disclosure or exclusion testing). For PGT this would mean potentially undergoing IVF unnecessarily if they are not actually a gene carrier. It would however protect them from any potential distress of knowing their own result if positive, while still being certain their baby is unaffected.
Other possibilities that may be available are choosing to foster or adopt, and couples might also want to consider sperm or egg donation. These options are available even where people don’t know the gene linked to inherited MND in their family and haven’t had genetic testing themselves.
There are many factors which can influence which options are available and right for different people. More information about these and other options is available on the MND Association website. People may benefit from talking to a genetic counsellor or other healthcare professionals.
Knowledge and views on pre-implantation genetic testing and pre-natal testing during pregnancy
Some people we spoke to were aware of reproductive options to prevent passing on a genetic variant of inherited MND to future generations. Genetic counsellors could be helpful in explaining options like PGT, and others had been told by different healthcare professionals (such as neurologists) or by family members. Not everyone had been told about these options or looked into them further, especially where it was not relevant to their situation.
People had different opinions on using genetic testing before or during pregnancy to prevent passing on a gene variant to the next generation. Some people didn’t have strong feelings or hadn’t really thought about it before. Other people felt that there was nothing wrong with using options like pre-natal testing or PGT.
Like Lizbeth, Maggie drew a comparison between using medical technologies to prevent illness and for other uses. She said, “We have used medical knowledge and science and things to our advantage, it would be foolish to suddenly turn around and say, ‘No that’s wrong’. I think some things probably are wrong, designer babies and all that sort of stuff, but if you can get rid of a rogue gene…then why wouldn’t you?”
Some people’s views were informed by previous experiences, including of seeing relatives affected by MND. A few individuals had faced decisions over testing in pregnancy for other conditions. Paul emphasised respecting “the variety of life”, but Niki said, “I personally believe very strongly in the quality of life, and have no qualms about any kind of selective action, but that wouldn’t be everybody’s way”. Richard felt that some people might see using genetic testing before pregnancy as interfering with “mother nature”, but for him, “my view is that anything that stops people having to see what I saw with my mum trumps that”.
Some people had concerns about using pre-natal testing for inherited MND, particularly around terminating a pregnancy, which they felt was a difficult decision or hard to justify given the uncertainty of whether a baby would actually develop MND. Sheenagh said, “if you have that gene, it doesn’t mean you’re going to have the disease. And if you don’t have that gene, it doesn’t mean you’re not going to have the disease… there’s nothing conclusive about it”.
People also had particular views on PGT. JW said, “I thought it was some clever thing you could do… But actually it’s just yes, no, no, yes… it sounds brutal but I’m all in favour of it. I wouldn’t have any moral objections to it because being conceived is a fairly random act anyway”. A few people pointed out the physical and emotional, financial and practical costs of IVF, as well as the limited success rate. From her experience as a children’s intensive care nurse, Sarah said, “you can test to your heart’s content for various things… but you can still have other problems that arise within your life”. Another view was that using PGT was like “playing God”.
Helen would want her children to have information on reproductive options when they come to make decisions on starting a family. Other people also felt it was important to share information about inherited MND in the wider family so everyone has a chance to make informed choices. Some people hoped their children would use options like PGT to prevent the disease in the next generation. Whilst a few said they would encourage this, others emphasised that it was their child’s choice.
Some people confused PGT with gene editing or removing a gene, but it is important to make clear that PGT does not involve gene editing, but rather the genetic testing and selection of embryos.
Experiences of using pre-implantation genetic testing
One person we spoke to had used PGT to try and prevent a future child from inheriting the genetic variant linked to MND that she carried. Harriet’s mum was diagnosed with MND when she was pregnant with her first child, and this was identified as an inherited form after his birth. For Harriet, having pre-symptomatic genetic testing to find out if she had inherited the C9orf72 gene variant was a “no-brainer”; she and her husband wanted another child but felt a “moral duty” to find out her result before going ahead.
Harriet received a positive pre-symptomatic genetic test result, and she and her husband decided to go ahead with PGT to try for their second child; they didn’t feel that other options, like pre-natal testing for inherited MND, were right for them. Harriet believes in other people’s right to choose to end a pregnancy, but she personally would find it difficult to have a termination on the basis of something that might or might not happen, especially given research progress.
Unlike most people we spoke to, Harriet hadn’t seen a genetic counsellor before having the pre-symptomatic genetic test, as she had spoken to a neurologist instead. Because of this, Harriet and her husband were required to have a genetic counselling session before starting the PGT process.
After the PGT failed, what was a “black and white” decision became “fuzzy and grey” as Harriet and her husband considered their options going forwards.
After a second round of PGT failed, Harriet and her husband decided they would try for a second baby on their own; after looking into current research on genetic therapies, they feel confident that there will be a treatment available in the near future.
Although other people we spoke to had not used PGT themselves, one person, who asked not to be identified, described how a relative had her first child through PGT, conceived after the third round of IVF. Like Harriet, one reason she wanted a second child was so her existing child had the support of a sibling, particularly if she became ill. Although the first three rounds of IVF were funded by the NHS, any further treatment had to be paid for privately. After two further rounds of IVF were unsuccessful, she and her partner decided to try for a second baby on their own. As well as the financial cost, the physical strain of IVF was a factor in this decision, “It’s a big decision though, but they couldn’t afford IVF and anyway, the IVF treatment is…not a nice thing to go through. It sounds like you have a quick pill and you’re fine, but it’s amazing the amount of rubbish you go through. She just couldn’t face doing it again”.
This person acknowledged that having one child who does not carry the C9orf72 gene variant, and one who has a 50% chance of having inherited it could cause some difficult conversations in the future. However, this person supports the decision to have another baby anyway. “The advantages have already begun; the disadvantages won’t emerge for several decades, so what the hell”.